MHRA and Covid Vaccines Surveillance [Article From 13/12/24]

ur series on Pfizer’s Comirnaty vaccine was sparked off by a remark from one of our readers.

He is an eye doctor who saw an abnormally high number of cases of Bell’s Palsy during the months of the vaccine’s rollout—perhaps we should say vaccines. Bell’s Palsy is a frightening progressive weakness of facial muscles, usually one-sided. Most cases recover, but some do not. At the time, we asked, “How would you like to go around with half your face hanging down and unable to see properly?”

We have summarised our series of posts on Comirnaty and ask you to refresh your memory before reading further. At the bottom of this post is a series of relevant pieces we have produced since TTE began. 

The third of our summary posts wraps up how far we got.

We promised to keep tabs on any major step towards understanding the properties of Comirnaty, having identified some very large gaps in the evidence base.

One of the most contentious parts of the whole saga (apart from the mode of action) is the potential harms of the Covid vaccines. The Oxford AstraZeneca vaccine’s demise is a case in point.

In this post, we reported that in response to a 2022 FOI request on the number of Yellow Card reports for Bell’s Palsy over the previous three years (FOI 21-750), the MHRA responded:

Read More – MHRA and Covid Vaccines Surveillance [Article From 13/12/24]